|Author(s)/Faculty: Carmen A. Puliafito, MD, MBA; David M. Brown, MD, FACS; Jeffrey S. Heier, MD; Peter K. Kaiser, MD|
|Release Date: 12/5/2014||Expiration Date: 12/4/2015|
|Credit Type: CME||Number of Credits: 0|
|Content Type: Multimedia||Provider: |
|This slides-audio lectures discusses evaluating the latest clinical data regarding the use of VEGF inhibitors and other agents in the treatment of neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME), applying the latest clinical evidence about VEGF inhibitors and other drugs available for the treatment of retinal vein occlusion (RVO) to promote the design of safe and effective therapeutic regimens and optimizing the use of optical coherence tomography and fluorescein angiography in the diagnosis and monitoring of patients with AMD, DME, and RVO.